News —

Fight against cancer - Attana's collaborator interviewed

Attana's collaborator at Gothenburg University, Dr. Sture Lindegren, is interviewed in one of Sweden's largest newspapers (Svenska Dagbladet) about a possible new cure for ovarian cancers. Using the Attana Cell 200 instrument, Dr. Lindegren and his team are testing antibodies as carriers of radionuclide that target cancer cells directly instead of affecting the whole body as current cancer therapies do. For more information on how the Attana Cell 200 was utilized by the team to obtain biologically relevant data, please see our application note Early detection of clinical failure, also included below.

The article (in Swedish) can be found here: http://doc.mediaplanet.com/all_projects/5477.pdf, page 18

Topics

  • Medical research
  • Medicine, Pharmaceuticals
  • Natural science
  • Medicine

Categories

  • ovarian cancer
  • cancer
  • biosensor
  • attana cell 200
  • Attana Application Note: Glycosylation profile of cancer cells
    License:
    Media Use
    File format:
    .pdf
    Download
  • Attana Application Note: Early detection of clinical failure
    License:
    Media Use
    File format:
    .pdf
    Download
  • Attana Application Note: Characterization of complex lectin-cell kinetics
    License:
    Media Use
    File format:
    .pdf
    Download

Related events